Back to Search
JOHN CHAN, MD
Gynecologic Oncology Physician
NPI: 1962596551IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology Physician
Obstetrics & Gynecology
Code: 207V00000X
A61661(CA)
Gynecologic Oncology PhysicianPrimary
Obstetrics & Gynecology — Gynecologic Oncology
Code: 207VX0201X
A61661(CA)
Education
UNIVERSITY OF CALIFORNIA, GEFFEN SCHOOL OF MEDICINE
Class of 1995
Research & Publications (20)
Sweets, sweetened beverages, and risk of pancreatic cancer in a large population-based case-control study.
PMID 19277880·Cancer Causes Control·2009
8-other
A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates.
PMID 19443683·Proc Natl Acad Sci U S A·2009
7-preclinical
Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer.
PMID 19528373·J Clin Oncol·2009
4-observational
Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer.
PMID 17949796·Gynecol Oncol·2008
8-other
The influence of conservative surgical practices for malignant ovarian germ cell tumors.
PMID 18563734·J Surg Oncol·2008
8-other
Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success?
PMID 18285603·J Clin Oncol·2008
4-observational
Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
PMID 18395777·Gynecol Oncol·2008
8-other
Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
PMID 18348296·Cancer·2008
4-observational
The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?
PMID 18349835·Br J Cancer·2008
8-other
Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States.
PMID 17979133·J Surg Oncol·2008
4-observational
Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer.
PMID 18226629·Am J Obstet Gynecol·2008
8-other
The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients.
PMID 17667929·Br J Cancer·2007
8-other
The outcomes of 27,063 women with unstaged endometrioid uterine cancer.
PMID 17662377·Gynecol Oncol·2007
4-observational
Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients.
PMID 17503431·Cancer·2007
8-other
Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
PMID 17540806·Obstet Gynecol·2007
8-other
Role of complete lymphadenectomy in endometrioid uterine cancer.
PMID 17765192·Lancet Oncol·2007
4-observational
A novel technique for the enrichment of primary ovarian cancer cells.
PMID 17980191·Am J Obstet Gynecol·2007
8-other
Pancreatic cancer, animal protein and dietary fat in a population-based study, San Francisco Bay Area, California.
PMID 17805983·Cancer Causes Control·2007
7-preclinical
The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients.
PMID 17519907·Br J Cancer·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1100 VAN NESS AVE FL 4
SAN FRANCISCO, CA 94109 - Phone
- (415) 600-0930
Quick Facts
- NPI
- 1962596551
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile